Rivastigmine for Dementia Associated with Parkinson's Disease
0
Authors
Murat Emre
Murat Emre•Dag Aarsland•Roger Lane
Published
December 9, 2004
Abstract
Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients.
